首页> Lung cancer (Amsterdam, Netherlands)> International real-world study of DLL3 expression in patients with small cell lung cancer.

International real-world study of DLL3 expression in patients with small cell lung cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Federico,Rojo

第一单位： Hospital Universitario Fundación Jiménez Díaz CIBERONC, Madrid, Spain. Electronic address: frojo@fjd.es.

作者： Federico,Rojo ^[1] ; Marcelo,Corassa ^[2] ; Dimitrios,Mavroudis ^[3] ; Aysim Büge,Öz ^[4] ; Bonne,Biesma ^[5] ; Luka,Brcic ^[6] ; Patrick,Pauwels ^[7] ; Verena,Sailer ^[8] ; John,Gosney ^[9] ; Darko,Miljkovic ^[10] ; Carlos,Hader ^[10] ; Meijing,Wu ^[10] ; Todd,Almarez ^[10] ; Frédérique,Penault-Llorca ^[11]

作者单位： Hospital Universitario Fundación Jiménez Díaz CIBERONC, Madrid, Spain. Electronic address: frojo@fjd.es. ^[1] A.C. Camargo Cancer Center, São Paulo, Brazil. ^[2] University General Hospital of Heraklion, Heraklion, Greece. ^[3] Istanbul University Cerrahpaşa, Faculty of Medicine, Istanbul, Turkey. ^[4] Jeroen Bosch Ziekenhuis,' s-Hertogenbosch, Netherlands. ^[5] Medical University of Graz, Graz, Austria. ^[6] Centre for Oncological Research (CORE), University of Antwerp, and University Hospital Antwerp, Edegem, Belgium. ^[7] University Hospital Schleswig-Holstein, Lübeck, Germany. ^[8] Liverpool University Hospitals, Liverpool, United Kingdom. ^[9] AbbVie Inc., North Chicago, IL, United States. ^[10] University Clermont Auvergne, Jean Perrin Center, INSERM, IMoST, 63000 Clermont-Ferrand, France. ^[11]

关键词 Biomarker DLL3 Real-world analysis Small cell lung cancer